20/20 HealthCare Partners

20/20 HealthCare Partners LLC is a Global Investment Group that invests primarily at the earliest stage of technology & life science innovation. We have a long history of creating value by partnering with entrepreneurs, executives and strategic partners in the healtcare community. Through strategic advice, team building, product development and syndicated investment, we are committed to helping our partners build valuable companies that impact healthcare and improve quality of life.

Hillel Bachrach

Managing Partner

11 past transactions

Variantyx

Series C in 2021
Based on clinical whole genome sequencing (WGS) and using a single patient sample, Variantyx's Genomic Unity® test identifies and reports all major variant types including small sequence changes, structural variants, mitochondrial variants and short tandem repeat expansions. This comprehensive test test eliminates the need for traditional step-wise, reiterative genetic testing.

Coagulo Medical Technologies

Venture Round in 2020
Coagulo is transforming medicine with the first portable and connected precision-medicine platform for smarter management of coagulation, enabling better healthcare outcomes for everyone.

XRHealth

Venture Round in 2020
XRHealth is a medical device company that develops an XR (VR\AR) therapeutic platform. The company focuses on using immersive technologies to enhance patient care, improve medical treatments, and provide innovative solutions for various health-related challenges.

EnClear Therapies

Series A in 2020
EnClear Therapies is a Cambridge (USA) based life sciences company developing a device-based therapy to aid in the treatment of neurodegenerative disease and delivery and monitoring of cerebrospinal fluid (CSF). EnClear’s proprietary therapeutic platform focuses on removing toxic proteins from the CSF. The company’s first products will target improving the lives of patients with Amyotrophic Lateral Sclerosis (ALS) and Progressive Supranuclear Palsy (PSP).

Verseau Therapeutics

Venture Round in 2019
Verseau is creating a new class of therapeutics, macrophage checkpoint modulators, to benefit patients with cancer, immune and inflammatory diseases. The company's modulators identify novel targets and develop therapies that shift macrophages between immune activators and silencers in disease, enabling physicians to benefit patients from immunotherapy.

SQZ Biotech

Series A in 2015
SQZ Biotech is a developer of a cell engineering technology designed to deliver a diverse set of materials into patient cells. It is a privately held company that develops cellular therapies for multiple indications using the proprietary CellSqueeze technology. Through internal research programs and external partnerships, SQZ’s unique cell engineering capabilities are being used to develop a new generation of cell therapies by engineering the immune system both through immune activation and immune suppression for a wide range of clinical challenges.

EightSpokes, Inc.

Venture Round in 2015
EightSpokes is an intelligent cloud-based solution for programme and portfolio management in the life sciences. It also provides a solution for launch and programme management, lifecycle management, mergers and acquisitions, collaborative planning, and synchronised execution.

Physiq

Venture Round in 2013
physIQ has developed a personalized physiology analytic platform (PPA) for use in both the regulated healthcare market as well as the unregulated health and fitness market. The technology is designed to detect subtle changes in vital signs and other health indicators to help clinicians manage patients with chronic illness, and to help consumers track their own health and fitness levels. The key differentiator between the physIQ platform and other technologies is that it constructs a personalized baseline norm for each person monitored, rather than simple trending or comparison to population-based statistics. Our technology can also be embedded into patient monitoring devices from other manufacturers who are seeking to design "smarter" products.

QBotix

Series A in 2012
A solar panel that tracks the sun throughout the day produces up to 30% more electricity than one that does not. Solar project developers install single-axis tracking for most utility-scale sites, balancing upfront costs versus electricity revenues to maximize rates of return. QBotix disrupts today's cost curve of fixed-tilt, single-axis tracking, and dual-axis tracking with an innovative tracking solution that offers dual-axis tracking at single-axis price. This reduces the levelized cost of energy by 10-20% while providing the added benefit of higher reliability and system intelligence.

Velocomp

Venture Round in 2011
Velocomp is a sports technology company that offers a range of power measurement tools for bicycles worldwide. Its products include iSport, a wireless cycling computer and power meter; iPro, a product which helps in tracking progress and analyzing rides; iBike POWERHOUSE, a cycling computer that automatically adjusts to exercise goals; iAero, a product which helps in power and wind tunnel measurements; iDash CC, a cycling computer; iDash CC Deluxe, a fitness computer; iDash +Power, a dashboard for training and fitness; and protective bicycle cases and mounts for iPhone and iPod touch.

Zixi

Venture Round in 2011
Zixi is the leading enabler of flawless broadcast quality HDTV over the Internet. Broadcasters, enterprises, and video-on-demand services use Jixi to enrich the user experience, create new services, and significantly reduce costs. Jixi enables the delivery of live and on-demand HD video content over the Internet in real time and with unprecedented quality. The technology is applicable for multi-media delivery and consumption across a spectrum of industries.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.